Humana Inc. Reports Strong Q2 2025 Earnings and Raises Guidance

Humana ( (HUM) ) has released its Q2 earnings. Here is a breakdown of the information Humana presented to its investors.

Humana Inc. is a leading health insurance company based in Louisville, Kentucky, primarily serving Medicare and Medicaid beneficiaries, and offering a range of healthcare services through its CenterWell segment. In its latest earnings report, Humana announced a second-quarter GAAP earnings per share (EPS) of $4.51 and an adjusted EPS of $6.27, with year-to-date adjusted EPS reaching $17.85. The company reported a revenue increase to $32.4 billion for the quarter, up from $29.5 billion the previous year, and raised its full-year 2025 revenue guidance to at least $128 billion.

Key financial highlights include a benefit ratio of 89.9% for the insurance segment, aligning with expectations, and an increase in the full-year adjusted EPS guidance to approximately $17.00. Humana also anticipates a decline in individual Medicare Advantage membership by up to 500,000 members, a revision from the previous estimate of 550,000, as part of its strategy to exit unprofitable plans. The company continues to expand its CenterWell segment, with anticipated net patient growth exceeding prior expectations.

Strategically, Humana is focusing on sustainable long-term value creation by prioritizing benefit structures and expanding its footprint in the CenterWell and Medicaid markets. The CenterWell Pharmacy recently gained access to 17 new limited distribution drugs and received the MMIT Patient Choice award for the seventh time in eight years.

Looking ahead, Humana remains confident in its pricing strategy and operational excellence initiatives, aiming to drive improved outcomes and customer experiences. The company continues to invest in its strategic initiatives, positioning itself for sustained growth and value creation in the healthcare sector.